Choroidal neovascularization

Frances E. Kane, Peter A Campochiaro

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Despite substantial recent progress in treatment development, choroidal neovascularization (CNV) remains one of the most challenging problems faced by retina specialists. It is a common cause of severe visual loss in patients with age-related macular degeneration (AMD) and younger patients with one of many diseases that affect the choroid-Bruch’s membrane-retinal pigment epithelium (RPE) complex, including but not limited to ocular histoplasmosis, myopic degeneration, angioid streaks, and multifocal choroiditis. As our understanding of the molecular pathogenesis of CNV is increasing, new treatments are being developed which specifically target molecules that are involved. Therefore, it is critical to continue to elucidate the molecular mechanisms involved in CNV.

Original languageEnglish (US)
Title of host publicationAge-Related Macular Degeneration, Second Edition
PublisherCRC Press
Pages87-96
Number of pages10
ISBN (Electronic)9781420019865
ISBN (Print)9780849372148
StatePublished - Jan 1 2007

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Choroidal neovascularization'. Together they form a unique fingerprint.

  • Cite this

    Kane, F. E., & Campochiaro, P. A. (2007). Choroidal neovascularization. In Age-Related Macular Degeneration, Second Edition (pp. 87-96). CRC Press.